Skip to main content
Log in

ABF-1 is frequently silenced by promoter methylation in follicular lymphoma, diffuse large B-cell lymphoma and Burkitt's lymphoma

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4

References

  1. Massari ME, Rivera RR, Voland JR, Quong MW, Breit TM, van Dongen JJ et al Characterization of ABF-1, a novel basic helix-loop-helix transcription factor expressed in activated B lymphocytes. Mol Cell Biol 1998; 18: 3130–3139.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Zhao F, Vilardi A, Neely RJ, Choi JK . Promotion of cell cycle progression by basic helix-loop-helix E2A. Mol Cell Biol 2001; 21: 6346–6357.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Mathas S, Janz M, Hummel F, Hummel M, Wollert-Wulf B, Lusatis S et al. Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma. Nat Immunol 2006; 7: 207–215.

    Article  CAS  PubMed  Google Scholar 

  4. Renne C, Martin-Subero JI, Eickernjager M, Hansmann ML, Kuppers R, Siebert R et al. Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma. Am J Pathol 2006; 169: 655–664.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Kuppers R, Klein U, Schwering I, Distler V, Brauninger A, Cattoretti G et al. Identification of Hodgkin and Reed–Sternberg cell-specific genes by gene expression profiling. J Clin Invest 2003; 111: 529–537.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Lietz A, Janz M, Sigvardsson M, Jundt F, Dorken B, Mathas S . Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis. Br J Haematol 2007; 137: 342–348.

    Article  CAS  PubMed  Google Scholar 

  7. Ushijima T, Okochi-Takada E . Aberrant methylations in cancer cells: where do they come from? Cancer Sci 2005; 96: 206–211.

    Article  CAS  PubMed  Google Scholar 

  8. Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 2003; 198: 851–862.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This study was supported in part by grant 107547 from Deutsche Krebshilfe eV to TW and AU.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T Wirth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ushmorov, A., Leithäuser, F., Ritz, O. et al. ABF-1 is frequently silenced by promoter methylation in follicular lymphoma, diffuse large B-cell lymphoma and Burkitt's lymphoma. Leukemia 22, 1942–1944 (2008). https://doi.org/10.1038/leu.2008.70

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2008.70

  • Springer Nature Limited

This article is cited by

Navigation